The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Advanced glycation endproducts: what is their relevance to diabetic complications?
Abstract
Glycation is a major cause of spontaneous damage to proteins in physiological systems. This is exacerbated in diabetes as a consequence of the increase in glucose and other saccharides derivatives in plasma and at the sites of vascular complications. Protein damage by the formation of early glycation adducts is limited to lysine side chain and N‐terminal amino groups whereas later stage adducts, advanced glycation endproducts (AGEs), modify these and also arginine and cysteine residues. Metabolic dysfunction in vascular cells leads to the increased formation of methylglyoxal which adds disproportionately to the glycation damage in hyperglycaemia. AGE‐modified proteins undergo cellular proteolysis leading to the formation and urinary excretion of glycation free adducts. AGEs may potentiate the development of diabetic complications by activation of cell responses by AGE‐modified proteins interacting with specific cell surface receptors, activation of cell responses by AGE free adducts, impairment of protein–protein and enzyme–substrate interactions by AGE residue formation, and increasing resistance to proteolysis of extracellular matrix proteins. The formation of AGEs is suppressed by intensive glycaemic control, and may in future be suppressed by thiamine and pyridoxamine supplementation, and several other pharmacological agents. Increasing expression of enzymes of the enzymatic defence against glycation provides a novel and potentially effective future therapeutic strategy to suppress protein glycation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 2×
“Journal Compilation # 2006 Blackwell Publishing Ltd Diabetes, Obesity and Metabolism, 9, 2007, 233–245 j 239 N. Ahmed and P. J. Thornalley Advanced glycation endproducts j RA type 1 and type 2 diabetes [ 86 ].”
BackgroundProtein degradation and protection against misfolded or damaged proteins.
Goldberg, A. L. (2003) · Nature · doi:10.1038/nature02263 · Cited by 2,088
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Park, J. S., Svetkauskaite, D., He, Q., Kim, J.-Y., Strassheim, D., Ishizaka, A., & Abraham, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,562
Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix
Sell, D. R., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88225-8 · Cited by 1,081
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products
Verzijl, N., DeGroot, J., Thorpe, S. R., Bank, R. A., Shaw, J. N., Lyons, T. J., Bijlsma, J. W. J., Lafeber, F. P. J. G., Baynes, J. W., & TeKoppele, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006700200 · Cited by 963
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 869
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785 · cited 1×
“High-dose thiamine and Benfotiamine therapy decreased the formation of methylglyoxal-derived AGEs in experimental diabetes without improvement in glycaemic control [6, 87 ].”
BackgroundYONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal · doi:10.1042/bj20021371 · Cited by 716
Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
Thornalley, P. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.013 · Cited by 682
Self-citationIntracellular functions of galectins
Liu, F. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00313-6 · Cited by 675
THORNALLEY, P. J., BATTAH, S., AHMED, N., KARACHALIAS, N., AGALOU, S., BABAEI-JADIDI, R., & DAWNAY, A. (2003) · Biochemical Journal · doi:10.1042/bj20030763 · Cited by 659
Self-citationStehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652
Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycation
Thornalley, P. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311343 · Cited by 614
Self-citationWendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications
McLellan, A. C., Thornalley, P. J., Benn, J., & Sonksen, P. H. (1994) · Clinical Science · doi:10.1042/cs0870021 · Cited by 557
Self-citationThe Diabetes Control and Complications Trial Research Group (1994) · Retina · doi:10.1097/00006982-199414030-00022 · Cited by 551
Reddy, S., Bichler, J., Wells-Knecht, K. J., Thorpe, S. R., & Baynes, J. W. (1995) · Biochemistry · doi:10.1021/bi00034a021 · Cited by 524
Immunochemical detection of advanced glycosylation end products in vivo.
Makita, Z., Vlassara, H., Cerami, A., & Bucala, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42741-x · Cited by 491
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Monnier, V. M., Bautista, O., Kenny, D., Sell, D. R., Fogarty, J., Dahms, W., Cleary, P. A., Lachin, J., & Genuth, S. (1999) · Diabetes · doi:10.2337/diabetes.48.4.870 · Cited by 469
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
Vasan, S., Zhang, X., Zhang, X., Kapurniotu, A., Bernhagen, J., Teichberg, S., Basgen, J., Wagle, D., Shih, D., Terlecky, I., et al. (1996) · Nature · doi:10.1038/382275a0 · Cited by 466
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 462
Breakers of advanced glycation end products restore large artery properties in experimental diabetes
Wolffenbuttel, B. H. R., Boulanger, C. M., Crijns, F. R. L., Huijberts, M. S. P., Poitevin, P., Swennen, G. N. M., Vasan, S., Egan, J. J., Ulrich, P., Cerami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4630 · Cited by 434
Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421
Thornalley, P. J. (1998) · PubMed · Cited by 387
Self-citationPyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., & Baynes, J. W. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00207.x · Cited by 378
Vlassara, H., Fuh, H., Makita, Z., Krungkrai, S., Cerami, A., & Bucala, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12043 · Cited by 377
Prevention of Incipient Diabetic Nephropathy by High-Dose Thiamine and Benfotiamine
Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S., & Thornalley, P. J. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2110 · Cited by 373
Self-citationReactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
Makita, Z., Bucala, R., Rayfield, E. J., Fuh, H., Manogue, K. R., Cerami, A., Viassara, H., Friedman, E. A., Kaufman, A. M., Korbet, S. M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92935-1 · Cited by 373
Extracellular functions of galectin-3
Ochieng, J., Furtak, V., & Lukyanov, P. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014082.99675.2f · Cited by 370
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
Stitt, A., Gardiner, T. A., Anderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2826 · Cited by 355
AHMED, N., ARGIROV, O. K., MINHAS, H. S., CORDEIRO, C. A. A., & THORNALLEY, P. J. (2002) · Biochemical Journal · doi:10.1042/bj3640001 · Cited by 336
Self-citationHigh mobility group 1 B‐box mediates activation of human endothelium
Treutiger, C. J., Mullins, G. E., Johansson, A. ‐. M., Rouhiainen, A., Rauvala, H. M. E., Erlandsson‐Harris, H., Andersson, U., Yang, H., Tracey, K. J., Andersson, J., et al. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01204.x · Cited by 332
Fukushi, J.-I., Makagiansar, I. T., & Stallcup, W. B. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-03-0236 · Cited by 324
Ahmed, N., Dobler, D., Dean, M., & Thornalley, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410973200 · Cited by 314
Self-citationIn Vitro Kinetic Studies of Formation of Antigenic Advanced Glycation End Products (AGEs)
Booth, A. A., Khalifah, R. G., Todd, P., & Hudson, B. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5430 · Cited by 286
Methylglyoxal-Derived Hydroimidazolone Advanced Glycation End-Products of Human Lens Proteins
Ahmed, N., Thornalley, P. J., Dawczynski, J., Franke, S., Strobel, J., Stein, G., & Haik, G. M. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0573 · Cited by 282
Self-citationChromatographic Quantitation of Plasma and Erythrocyte Pentosidine in Diabetic and Uremic Subjects
Odetti, P., Fogarty, J., Sell, D. R., & Monnier, V. M. (1992) · Diabetes · doi:10.2337/diab.41.2.153 · Cited by 255
Hemoglobin-AGE: A Circulating Marker of Advanced Glycosylation
Makita, Z., Vlassara, H., Rayfield, E., Cartwright, K., Friedman, E., Rodby, R., Cerami, A., & Bucala, R. (1992) · Science · doi:10.1126/science.1411574 · Cited by 251
Vlassara, H., Fuh, H., Donnelly, T., & Cybulsky, M. (1995) · Molecular Medicine · doi:10.1007/bf03401582 · Cited by 244
Chemical modification of proteins by methylglyoxal.
Degenhardt, T. P., Thorpe, S. R., & Baynes, J. (1998) · PubMed · Cited by 243
Ahmed, N., Babaei-Jadidi, R., Howell, S. K., Beisswenger, P. J., & Thornalley, P. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1810-7 · Cited by 237
Self-citationWestwood, M. E., & Thornalley, P. J. (1995) · Journal of Protein Chemistry · doi:10.1007/bf01886793 · Cited by 226
Self-citationSMEDSRØD, B., MELKKO, J., ARAKI, N., SANO, H., & HORIUCHI, S. (1997) · Biochemical Journal · doi:10.1042/bj3220567 · Cited by 226
A fast method to predict protein interaction sites from sequences
Gallet, X., Charloteaux, B., Thomas, A., & Brasseur, R. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4092 · Cited by 213
Biemel, K. M., Friedl, D. A., & Lederer, M. O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202681200 · Cited by 210
Forbes, J. M., Thorpe, S. R., Thallas-Bonke, V., Pete, J., Thomas, M. C., Deemer, E. R., Bassal, S., El-Osta, A., Long, D. M., Panagiotopoulos, S., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010062 · Cited by 210
Kilhovd, B. K., Giardino, I., Torjesen, P. A., Birkeland, K. I., Berg, T. J., Thornalley, P. J., Brownlee, M., & Hanssen, K. F. (2003) · Metabolism · doi:10.1053/meta.2003.50035 · Cited by 187
Self-citationAccelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice
PUGLIESE, G., PRICCI, F., IACOBINI, C., LETO, G., AMADIO, L., BARSOTTI, P., FRIGERI, L., HSU, D. K., VLASSARA, H., LIU, F.-T., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0006com · Cited by 184
The Potential Role of Thiamine (Vitamin B1) in Diabetic Complications
Thornalley, P. (2005) · Current Diabetes Reviews · doi:10.2174/157339905774574383 · Cited by 183
Self-citationValencia, J. V., Weldon, S. C., Quinn, D., Kiers, G. H., DeGroot, J., TeKoppele, J. M., & Hughes, T. E. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2003.09.013 · Cited by 178
Ahmed, N., Mirshekar-Syahkal, B., Kennish, L., Karachalias, N., Babaei‐Jadidi, R., & Thornalley, P. J. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500008 · Cited by 174
Self-citationBerlanga, J., Cibrián, D., Guillén, I., Freyre, F., Alba, J. S., López-Saura, P. A., Merino, N., Aldama, A., Quintela, A. M., Triana, M. E., et al. (2005) · Clinical Science · doi:10.1042/cs20050026 · Cited by 173
Self-citationNakamura, Y., Kawakami, M., Yoshihiro, A., Miyoshi, N., Ohigashi, H., Kawai, K., Osawa, T., & Uchida, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109760200 · Cited by 169
RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs)
Collison, K. S., Parhar, R. S., Saleh, S. S., Meyer, B. F., Kwaasi, A. A., Hammami, M. M., Schmidt, A. M., Stern, D. M., & Al-Mohanna, F. A. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.433 · Cited by 164
Profound Mishandling of Protein Glycation Degradation Products in Uremia and Dialysis
Agalou, S., Ahmed, N., Babaei‐Jadidi, R., Dawnay, A., & Thornalley, P. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080635 · Cited by 163
Self-citationPlasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Sugiyama, S., Miyata, T., Ueda, Y., Tanaka, H., Maeda, K., Kawashima, S., Van Ypersele de Strihou, C., & Kurokawa, K. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v991681 · Cited by 162
Sugimoto, K., Nishizawa, Y., Horiuchi, S., & Yagihashi, S. (1997) · Diabetologia · doi:10.1007/s001250050839 · Cited by 159
Takata, K., Horiuchi, S., Araki, N., Shiga, M., Saitoh, M., & Morino, Y. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68112-8 · Cited by 154
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase.
Delpierre, G., Rider, M. H., Collard, F., Stroobant, V., Vanstapel, F. J. L. A., Santos, H., & SCHAFTINGEN, E. V. (2000) · Diabetes · doi:10.2337/diabetes.49.10.1627 · Cited by 154
Ahmed, N., & Thornalley, P. J. (2002) · Biochemical Journal · doi:10.1042/bj3640015 · Cited by 152
Self-citationDetermination of Nϵ-carboxymethyllysine in milk products by a modified reversed-phase HPLC method
Drusch, S., Faist, V., & Erbersdobler, H. F. (1999) · Food Chemistry · doi:10.1016/s0308-8146(98)00244-1 · Cited by 144
Yee, N. S., Langen, H., & Besmer, P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85226-2 · Cited by 137
Pyridoxamine: The Many Virtues of a Maillard Reaction Inhibitor
Voziyan, P., & Hudson, B. G. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.093 · Cited by 117
Manley, S. E. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.182 · Cited by 116
Chronic Vascular Inflammation in Patients With Type 2 Diabetes
Feng, L., Matsumoto, C., Schwartz, A. B., Schmidt, A. M., Stern, D. M., & Pile‐Spellman, J. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.379 · Cited by 103
Cooper, M. E., Thallas, V., Forbes, J. M., Scalbert, E., Sastra, S. A., Darby, I. A., & Soulis, T. (2000) · Diabetologia · doi:10.1007/s001250051355 · Cited by 102
High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats
Babaei‐Jadidi, R., Karachalias, N., Kupich, C., Ahmed, N., & Thornalley, P. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1582-5 · Cited by 100
Self-citationKoito, W., Araki, T., Horiuchi, S., & Nagai, R. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh193 · Cited by 93
Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSA
Valencia, J., Mone, M. D., Zhang, J., Weetall, M. L., Buxton, F. P., & Hughes, T. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.743 · Cited by 93
Wilker, S. C., Chellan, P., Arnold, B. M., & Nagaraj, R. H. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.4992 · Cited by 91
Lieuw-a-Fa, M., van Hinsbergh, V. W. M., Teerlink, T., Barto, R., Twisk, J. W. R., Stehouwer, C. D. A., & Schalkwijk, C. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg619 · Cited by 91
Sasaki, S., Bao, Q., & Hughes, R. C. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199903)187:4<481::aid-path263>3.0.co;2-2 · Cited by 87
Wróbel, K., Wróbel, K., Garay‐Sevilla, M. E., Nava, L. E., & Malacara, J. M. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.9.1563 · Cited by 87
Yang, S., Litchfield, J., & Baynes, J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00015-8 · Cited by 81
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes
Thomas, M. C., Tsalamandris, C., MacIsaac, R. J., Medley, T. L., Kingwell, B. A., Cooper, M. E., Jerums, G., & Alberti, D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00868.x · Cited by 72
Mass spectrometric monitoring of albumin in uremia
Thornalley, P. J., Argirova, M., Ahmed, N., Mann, V. M., Argirov, O., & Dawnay, A. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00398.x · Cited by 69
Self-citationThornalley, P. J., & Minhas, H. S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00284-6 · Cited by 68
Self-citationPortero‐Otín, M., Pamplona, R., Ruiz, M. C., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2215 · Cited by 67
Suzuki, K., Koh, Y. H., Mizuno, H., Hamaoka, R., & Taniguchi, N. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021944 · Cited by 67
Ahmed, N., Thornalley, P. J., Luthen, R. E., Häussinger, D., Šebeková, K., Schinzel, R., Voelker, W., & Heidland, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.007 · Cited by 65
Self-citationPhosphate Transport in Yeast Vacuoles
Booth, J. W., & Guidotti, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20408 · Cited by 65
Effect of Maillard reaction products on protein digestion. Studies on pure compounds
Oeste, R. E., Miller, R., Sjoestroem, H., & Norén, O. (1987) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00078a020 · Cited by 65
Hayashi, C. M., Nagai, R., Miyazaki, K., Hayase, F., Araki, T., Ono, T., & Horiuchi, S. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000018826.59648.07 · Cited by 63
Galectin-3-positive cell infiltration in human diabetic nephropathy
Kikuchi, Y., Kobayashi, S., Hemmi, N., Ikee, R., Hyodo, N., Saigusa, T., Namikoshi, T., Yamada, M.-A., Suzuki, S., & Miura, S. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg603 · Cited by 62
Abbas, Z. G., & Swai, A. B. M. (1997) · PubMed · Cited by 61
Zhang, X., Medzihradszky, K. F., Cunningham, J. J., Lee, P., Rognerud, C. L., Ou, C., Harmatz, P., & Witkowska, H. E. (2001) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(01)00196-7 · Cited by 60
Effect of diabetes on vitamin B6 requirement in experimental animals
Okada, M., Shibuya, M., Yamamoto, E., et al. (1999) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.00028.x · Cited by 58
Turk, Z., Mesić, R., & Benko, B. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00128-4 · Cited by 46
Plasma levels of advanced glycation end products in children with renal disease
ebekov�, K., Podrack�, Bla?�?ek, P., Syrov�, D., Heidland, A., & Schinzel, R. (2001) · Pediatric Nephrology · doi:10.1007/s004670100038 · Cited by 45
Medina, L., & Haltiwanger, R. S. (1998) · Glycobiology · doi:10.1093/glycob/8.2.191 · Cited by 16
Detoxification of Methylglyoxal by the Nucleophilic Bidentate, Phenylacylthiazolium Bromide
Ferguson, G. P., VanPatten, S., Bucala, R., & Al‐Abed, Y. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990007y · Cited by 15
Smith, P. R., & Thornalley, P. J. (1992) · PubMed · Cited by 15
Self-citationSignificance of variation in turnover of glycated albumin on indices of diabetic control
Johnson, R. N., Easdale, R. W., Tatnell, M. A., & Baker, J. R. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90356-h · Cited by 14
Fluorometric Analysis for N'-Formylkynurenine in Plasma and Urine
Buxton, T. L., & Guilbault, G. G. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.7.765 · Cited by 12
Sensi, M., Morano, S., Morelli, S., Castaldo, P., Sagratella, E., Rossi, M. G. D., Andreani, D., Caltabiano, V., Vetri, M. G., Purrello, F., et al. (1998) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1998.00287.x · Cited by 11
Ng, R., Argirov, O. K., Ahmed, N., Weigle, B., & Thornalley, P. J. (2002) · International Congress Series · doi:10.1016/s0531-5131(02)00925-1 · Cited by 10
Self-citationSvistounov, D., Berg, T. J., McCourt, P., Zykova, S. N., Elvevold, K., Nagai, R., Horiuchi, S., & Smedsrød, B. H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.080 · Cited by 9
Cited by
The glycation of albumin: Structural and functional impacts
Rondeau, P., & Bourdon, E. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.003 · Cited by 433
Zhang, Q., Ames, J. M., Smith, R. D., Baynes, J. W., & Metz, T. O. (2009) · Journal of Proteome Research · doi:10.1021/pr800858h · Cited by 421
Hyperglycemia and Glycation in Diabetic Complications
Negre-Salvayre, A., Salvayre, R., Augé, N., Pamplona, R., & Portero-Otín, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2484 · Cited by 421
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Stirban, A., Gawlowski, T., & Roden, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 361
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 338
Metadata
- Authors
- Ahmed, N., & Thornalley, P. J.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2006-04-21
- Volume
- 9
- Issue
- 3
- Pages
- 233-245
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2138774341
- Cited by
- 371
- References
- 101
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.